Impacts of the COVID-19 Pandemic on Opioid Use Disorder and Services for American Indian and Alaska Native Communities
Parker DG, Radin S, Sorlagas N, Wendt DC., Health Res. 2025
Stable patterns, shifting risks: the impact of British Columbia’s decriminalization and recriminalization policies on drug use behaviours
Ali, F., Mende-Gibson, J., Russell, C., Torres-Salbach, S., Bardwell, G., Bonn, M., Budau, J., Ivsins, A., and Rehm, J., Harm Reduction Journal
Concordance Between Urine Drug Screening and Self-Reported Use in the Context of a Pragmatic Randomized-Controlled Trial in People with Prescription-Type Opioid Use Disorder: Concordance entre le dépistage de drogues dans l’urine et l’usage autodéclaré dans le contexte d’un essai pragmatique contrôlé à répartition aléatoire chez des personnes présentant un trouble lié à l’usage d’opioïdes vendus sur ordonnance
Bastien G, Abboud A, McAnulty C, Mahroug A, Le Foll B, Socias ME, Juteau LC, Dubreucq S, Jutras-Aswad D., Can J Psychiatry. 2025
Exploring unregulated substance use health data in Ontario, Canada: Identifying gaps, addressing challenges, and uncovering opportunities
Ali, F., Law, J., Russell, C., Imtiaz, S., Bayoumi, A., Werb, D., Rhem, J., Front. Public Health
Indigenous peoples and medications for opioid use disorders: A scoping review
Gala N, Dobischok S, Bernett P, Parker DG, O’Callahan A, Zentner D, Huson K, Tomaro J, Wendt DC., Psychol Addict Behav. 2025
Characterizing changes to harm reduction site operations in British Columbia following the implementation of the decriminalization of drugs: Findings from a provincial survey
Ali, F. , Russell,C., Law, J., Imtiaz, S., Budau, J., Shahin, R., MacKinnon, L., Griffith, S., Patenaude, S., Xavier, J., Rhem, J., Harm Reduction Journal
Physician perspectives on reducing harm and supporting emergency department patients who use drugs
Zoe K. D. Collins,Elaine Hyshka,Karine J. Lavergne,Savannah M. Weber,Ginetta Salvalaggio,Cindy Jiaxin Xue,Arlanna Pugh,Janusz Kaczorowski,Aaron M. Orkin,Andrew Kestler,Kathryn A. Dong, PLoS One
Scapegoated communities, shared struggles: A call for solidarity with people who use drugs and queer and trans people
Kira London‑Nadeau, Christian Barborini, Rebecca Haines‑Saah, Misha Bazarov, Sean Bristowe, Misha Khorkhordina, Mélodie Lemay‑Gaulin, Catherine Gorka, Robert‑Paul Juster, Heath D’Alessio, Nicholas Chadi, International Journal of Drug Policy, 2025
The erosion of safer supply programs in Ontario, Canada: A dangerous step backward
Ali, F., Sprakes, A., Mende-Gibson, J., Russell,C., Shaw, A., Bonn, M., Celinski, A., Kaminski, N., Karamouzian, M., Strike, C., Rhem, J., Drug Science, Policy and Law
Exploring Pain‑Severity and Psychological‑Flexibility Trajectories During Group‑Based Psychotherapy for Chronic Pain
Élisabeth Lamoureux, Karen Ghoussoub, Yoram Shir, Marc O. Martel, Zakhar Prylutskyy, M. Gabrielle Pagé, International Journal of Group Psychotherapy, 2025
